KR20120107076A - 산화질소를 포함하는 디히드로리포산 유도체 및 이의 치료적 용도 - Google Patents
산화질소를 포함하는 디히드로리포산 유도체 및 이의 치료적 용도 Download PDFInfo
- Publication number
- KR20120107076A KR20120107076A KR1020127012599A KR20127012599A KR20120107076A KR 20120107076 A KR20120107076 A KR 20120107076A KR 1020127012599 A KR1020127012599 A KR 1020127012599A KR 20127012599 A KR20127012599 A KR 20127012599A KR 20120107076 A KR20120107076 A KR 20120107076A
- Authority
- KR
- South Korea
- Prior art keywords
- compound
- group
- cooch
- butyl
- formula
- Prior art date
Links
- 0 *CC*CCC(C*C(*)(SN=O)I)SN=O Chemical compound *CC*CCC(C*C(*)(SN=O)I)SN=O 0.000 description 2
- ZGIUKEJVZWJZSU-BDWKERMESA-N CC(C)(CC(C/C=C/C=C/C(O)=O)SN=O)SN=O Chemical compound CC(C)(CC(C/C=C/C=C/C(O)=O)SN=O)SN=O ZGIUKEJVZWJZSU-BDWKERMESA-N 0.000 description 2
- SVPGPIHTFZNMCK-UHFFFAOYSA-N CCC(C)(CCC(CCCCC(O)=O)SN=O)SN=O Chemical compound CCC(C)(CCC(CCCCC(O)=O)SN=O)SN=O SVPGPIHTFZNMCK-UHFFFAOYSA-N 0.000 description 1
- JYZKGAJXQPPXLG-UHFFFAOYSA-N OC(C(CCC1)N1C(CCCCC(CCSN=O)SN=O)=O)=O Chemical compound OC(C(CCC1)N1C(CCCCC(CCSN=O)SN=O)=O)=O JYZKGAJXQPPXLG-UHFFFAOYSA-N 0.000 description 1
- BSDFHKAEOVSWAD-UHFFFAOYSA-N OC(C(CCCC1)N1C(CCCCC(CCS)S)=O)=O Chemical compound OC(C(CCCC1)N1C(CCCCC(CCS)S)=O)=O BSDFHKAEOVSWAD-UHFFFAOYSA-N 0.000 description 1
- LQNUQHUUROBOMN-UHFFFAOYSA-N OC(C(CCCC1)N1C(CCCCC1SSCC1)=O)=O Chemical compound OC(C(CCCC1)N1C(CCCCC1SSCC1)=O)=O LQNUQHUUROBOMN-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C313/00—Sulfinic acids; Sulfenic acids; Halides, esters or anhydrides thereof; Amides of sulfinic or sulfenic acids, i.e. compounds having singly-bound oxygen atoms of sulfinic or sulfenic groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C313/08—Sulfenic acids; Derivatives thereof
- C07C313/18—Sulfenamides
- C07C313/36—Sulfenamides having nitrogen atoms of sulfenamide groups further bound to other hetero atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/62—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
- C07D317/64—Oxygen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Hydrogenated Pyridines (AREA)
- Pyrrole Compounds (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US2010/024772 WO2010096677A2 (en) | 2009-02-17 | 2010-02-19 | Dihydrolipoic acid derivatives comprising nitric oxide and therapeutic uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20120107076A true KR20120107076A (ko) | 2012-09-28 |
Family
ID=45774361
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020127012599A KR20120107076A (ko) | 2010-02-19 | 2010-02-19 | 산화질소를 포함하는 디히드로리포산 유도체 및 이의 치료적 용도 |
Country Status (6)
Country | Link |
---|---|
JP (1) | JP2013507325A (ja) |
KR (1) | KR20120107076A (ja) |
AU (1) | AU2010215871A1 (ja) |
CA (1) | CA2777743A1 (ja) |
IL (1) | IL214785A0 (ja) |
RU (1) | RU2012103757A (ja) |
-
2010
- 2010-02-19 JP JP2011552969A patent/JP2013507325A/ja active Pending
- 2010-02-19 KR KR1020127012599A patent/KR20120107076A/ko not_active Application Discontinuation
- 2010-02-19 CA CA2777743A patent/CA2777743A1/en not_active Abandoned
- 2010-02-19 RU RU2012103757/04A patent/RU2012103757A/ru unknown
- 2010-02-19 AU AU2010215871A patent/AU2010215871A1/en not_active Abandoned
-
2011
- 2011-08-22 IL IL214785A patent/IL214785A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
CA2777743A1 (en) | 2010-08-26 |
RU2012103757A (ru) | 2013-12-20 |
IL214785A0 (en) | 2011-11-30 |
AU2010215871A1 (en) | 2012-11-15 |
JP2013507325A (ja) | 2013-03-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7384976B2 (en) | Nebivolol and its metabolites in combination with nitric oxide donors, compositions and methods of use | |
EP1438288B1 (en) | Substituted thioacetamides | |
US8816122B2 (en) | Prostratin analogs, bryostatin analogs, prodrugs, synthetic methods, and methods of use | |
US5874468A (en) | Brain targeted low molecular weight hydrophobic antioxidant compounds | |
JP2004528337A5 (ja) | ||
WO2010124201A2 (en) | Compositions and methods for treatment of cardiovascular disease | |
AU2009305619B2 (en) | Compositions and methods for treatment of renin-angiotensin aldosterone system (RAAS)-related disorders | |
US20120041025A1 (en) | Dihydrolipoic Acid Derivatives Comprising Nitric Oxide and Therapeutic Uses Thereof | |
KR20120107076A (ko) | 산화질소를 포함하는 디히드로리포산 유도체 및 이의 치료적 용도 | |
US6469064B2 (en) | Materials and methods for the treatment of depression | |
PL207703B1 (pl) | Nitrooksypochodne i ich zastosowanie | |
Khan et al. | New 4, 6-diacetyl resorcinol mannich bases: synthesis and biological evaluation | |
WO2000004001A1 (fr) | Piperazinones substituees et leurs applications en therapeutique | |
CH635844A5 (fr) | Thieno(3,2-c) et thieno(2,3-c)pyridines, leur procede de preparation et leur application en therapeutique. | |
WO2017085733A2 (en) | Improved process for the synthesis of 2, 6-xylidine and its derivatives | |
JP4001317B2 (ja) | 新規ウレタン、それらのチオ類似体及びジチオ類似体、これらの塩、これらの化合物を含む医薬組成物並びにそれらの使用及びそれらの調製方法 | |
CA2015626A1 (fr) | Derives benzothiazolinoniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent | |
RU2315040C1 (ru) | 3-гидроксипропиламид 4,6-диметил-1н-2-оксоникотиновой кислоты, проявляющий антикоагулянтную, противовоспалительную и анальгетическую активность | |
US20050054676A1 (en) | Materials and methods for the treatment of depression | |
RU2199537C1 (ru) | Триазиламиды 4-арил-2-гидрокси-4-оксо-3-(2-оксо-3,4-дигидро-2h-1,4-бензоксазинил)-2-бут еновой кислоты, проявляющие противовоспалительную активность | |
KR100687522B1 (ko) | 2,2-디메틸-3-에스테르-4-알콕시-6-알킬 아미노벤조피란 유도체를 유효성분으로 함유하는 pge2 활성에 관련된 염증질환 치료제 | |
EP1785417A2 (en) | Novel non-psychotropic cannabinoids | |
JP2008542262A (ja) | 2,2−ジメチル−3−アルキルエテール−4−アルコキシ−6−アルキルアミノベンゾピラン化合物またはその誘導体及びそれを有効成分として含むpge2生成抑制剤 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WITN | Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid |